Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 21, 2018 06:30 ET | Source: Freedom Leaf, Inc.

Freedom Leaf Enters $20 Billion Anti-Cholesterol Market With Acquisition of a Patent Pending Non-Prescription Formula. No FDA Approval Required. Complimentary Diversification In Health Care

While This Formula is Not Hemp Extract-Based, it Fits Perfectly with Our Focus on Health & Wellness, Including Our Ayurvedic Herbal Formulas Las Vegas, NV, June 21, 2018 (GLOBE NEWSWIRE) --...